Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1409 of 5804
-
Heavy drinking and risky sex: a text-based intervention aims to cut HIV risk
Disease control Recruiting nowHIV transmission remains a significant public health concern, especially among men who have sex with men (MSM). Condomless anal intercourse (CAI) continues to be the major route of transmission for MSM. Thus, to reduce the incidence of HIV, it is critical to identify how contextu…
Phase: NA • Sponsor: Boston University Charles River Campus • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a simple protein infusion boost brain function in liver disease?
Disease control Recruiting nowHypothesis: Improvement in cognitive dysfunction with IV albumin in patients with cirrhosis with prior HE and MHE lasts for several weeks after albumin infusion has ended, and is due to persistent improvement in inflammatory markers, endothelial dysfunction, albumin function and …
Phase: PHASE2 • Sponsor: Hunter Holmes Mcguire Veteran Affairs Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could a weekly shot replace daily HIV pills? new trial hints at possibility
Disease control CompletedA randomized, controlled, open-label, dose-exploration study to assess the effectiveness and safety of Lipovirtide combined with nucleoside drugs in HIV-infected patients who have not received antiviral treatment before.
Phase: PHASE2 • Sponsor: Shanxi Kangbao Biological Product Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could a sleep drug soothe PTSD? new study recruits troops and civilians
Symptom relief TerminatedThis is a Phase 2 randomized, double-blinded, placebo-controlled study that will evaluate multiple potential pharmacotherapeutic interventions for PTSD utilizing an adaptive platform trial design. Intervention C - Daridorexant will assess the safety and efficacy of daridorexant …
Phase: PHASE2 • Sponsor: Global Coalition for Adaptive Research • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Could a traditional chinese medicine help stop lung scarring?
Disease control Recruiting nowThis study evaluates the efficacy and safety of tetrandrine tablets (60 mg, three times daily) compared to placebo in adult patients with connective tissue disease-related interstitial lung disease. Patients receive standard treatment (glucocorticoids and immunosuppressants) alon…
Phase: PHASE4 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New hope for painful skin condition: experimental drug shows promise
Disease control TerminatedThis is a parallel, Phase 2, 2-arm, double-blind, randomized, multicenter, multinational, placebo-controlled study to evaluate efficacy, safety, pharmacokinetics (PK), and biological effects of treatment of subcutaneous injection of amlitelimab compared with placebo in male and f…
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Can a quick zap after liver surgery keep cancer away?
Disease control Recruiting nowRadiofrequency devices have been increasingly employed in liver surgery in order to achieve proper hemostasis and this use has become more evident with the implementation of minimal invasive surgery. Due to its well-known efficacy for tumor ablation (i.e. hepatocarcinoma) it use …
Phase: NA • Sponsor: Hospital del Mar • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Experimental CAR t combo trial halted early – only 2 patients enrolled
Disease control TerminatedThe purpose of the EXPAND study is to assess the safety and clinical efficacy of ALLO-647 combined with fludarabine and cyclophosphamide compared to fludarabine and cyclophosphamide alone in a lymphodepletion regimen prior to ALLO-501A CAR T therapy in adults with relapsed or ref…
Phase: PHASE2 • Sponsor: Allogene Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Pfizer RSV vaccine under the microscope: does it shield seniors from severe illness?
⭐️ VACCINE ⭐️ OngoingThe main purpose of this study is to learn about the effectiveness of Pfizer's ABRYSVO vaccine. This vaccine helps to prevent infections caused by Respiratory Syncytial Virus (RSV). RSV is a virus that can cause infections in the airways. These symptoms can be cold-like symptoms,…
Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:31 UTC
-
Magic mushroom compound shows promise for Tough-to-Treat depression and BPD
Symptom relief CompletedThe primary objective of the study is to evaluate the safety and efficacy of psilocybin in adults with major depressive disorder (MDD) and borderline personality disorder (BPD).
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
New antibody combo aims to control advanced prostate cancer
Disease control Recruiting nowThe purpose of Parts 1, 2A, and 2B of the study is to determine the recommended regimen for Phase 2 (RP2Rs) of combination of JNJ-87189401 with JNJ-78278343 and the purpose of Part 2C of this study is to determine how safe the RP2R(s) of the combination of JNJ-87189401 and JNJ-78…
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New pill aims to keep chemo on track for GI cancer patients
Disease control OngoingThe purpose of this study is to compare the efficacy of two study drugs, Avatrobopag versus placebo, to treat persistent Chemotherapy-Induced Thrombocytopenia (CIT) in patients with gastrointestinal (GI) malignancies receiving cytotoxic chemotherapy. The names of the study drugs…
Phase: PHASE2 • Sponsor: Hanny Al-Samkari, MD • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Double-Team biopsy could catch more dangerous prostate cancers
Diagnosis Recruiting now\*\*Study Goal:\*\* The purpose of this clinical trial is to determine if combining high-frequency micro-ultrasound with multiparametric MRI biopsy and a systematic biopsy can better detect clinically significant prostate cancer compared to current standard methods. This study is…
Phase: NA • Sponsor: Salzburger Landeskliniken • Aim: Diagnosis
Last updated Jun 27, 2026 13:04 UTC
-
Drug cocktail may cut transfusions for kids with thalassemia
Disease control CompletedThe goal of this clinical trial is to find out the efficacy of combined Hydroxyurea and thalidomide transfusion dependent thalassemia patients. The main objectives are to compare the level of Hb, Transfusion interval, serum ferritin level before \& after treatment between single …
Phase: PHASE4 • Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Brain zaps to kick the habit: new study for veterans with PTSD
Symptom relief Recruiting nowTobacco use is the number one preventable cause of the death in the United States, and is high among US Veterans, and those who have experienced trauma are more likely to smoke. Despite the efficacy of current evidence-based treatments for smoking cessation, there is a critical n…
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New calculator aims to predict best suicide prevention treatment for soldiers
Knowledge-focused Recruiting nowThe goal of this interventional study is to develop and test a treatment prognosis calculator to identify which service members with suicidal ideation or behavior are likely to respond well to the current standard of care treatment and which should instead receive Brief Cognitive…
Phase: NA • Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Sleeve that reads muscle signals may restore hand grasp in paralysis
Disease control CompletedThe goal of this pilot clinical study is to investigate the NeuroLife EMG-FES Sleeve System, a closed-loop approach to functional electrical stimulation, in adults (n=12) with chronic (\>12 months) tetraplegia due to spinal cord injury. Briefly, the NeuroLife EMG-FES System is a …
Phase: NA • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New 5-in-1 meningitis vaccine shows promise in early trial
⭐️ VACCINE ⭐️ CompletedThe purpose of VAN00010 study is to assess the safety and immunogenicity of the investigational pentavalent meningococcal ABCYW vaccine in adults and adolescents. The study duration will be up to 12 months for all participants.
Phase: PHASE1, PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:10 UTC
-
New imaging tool could spot Parkinson's years before symptoms worsen
Knowledge-focused Recruiting nowThe study is a longitudinal, multi-center study to assess progression of \[18F\] AV-133 imaging in Prodromal PD participants. Participants will be followed for up to 24 months. Approximately 100 Prodromal participants will be recruited from up to 10 sites. Participants will be co…
Phase: PHASE2 • Sponsor: Michael J. Fox Foundation for Parkinson's Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
New program aims to speed up radiation for head and neck cancer patients
Disease control Recruiting nowThe goal of this clinical trial is to compare the effectiveness of a navigation-based multilevel intervention (ENDURE) with treatment as usual (TAU) to improve the initiation of guideline-adherent postoperative radiation therapy among patients with head and neck cancer. The main …
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC